Physician profile
Bruce David Walker
NPI 1770571572
$52,440.78
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,624 · 2020: $20K · 2021: $3,660 · 2023: $13K · 2024: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $7,014 · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,087.50 |
| Travel and Lodging | $7,013.77 |
| Food and Beverage | $603.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $22,764.02 | 2019-2024 | |
| Pfizer INC. | $14,473.08 | 2023-2024 | |
| Viiv Healthcare Company | $7,513.56 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $4,732.14 | 2020 | |
| Abbvie INC. | $2,957.98 | 2019-2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.